Skip to main content

Want a detailed portfolio tracker?

Annovis Bio (ANVS) P/E (2020 - 2026)

Annovis Bio (ANVS) P/E from Mar 31, 2020 to Jul 20, 2026. The TTM Annovis Bio (ANVS) P/E is -1.03. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Annovis Bio (ANVS)

YearP/EChange
2026-1.03-60.73%
2025-2.61-1.77%
2024-2.66-31.39%
2023-3.88-16.72%
2022-4.65-50.93%
2021-9.48-0.08%
2020-9.49N/A

Comparison Annovis Bio (ANVS) P/E with competitors

Annovis Bio (ANVS) P/E is -1.03.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.17%
NBYStablecoin Development Corp0.00-100.42%
ENLVEnlivex Ltd0.07-107.29%
FGENFibroGen Inc0.24-123.40%
CHRSCoherus Biosciences Inc0.85-182.72%
FBIOFortress Biotech Inc0.95-192.52%
ORMPOramed Pharmaceuticals Inc1.50-246.53%
AGENAgenus Inc3.01-393.39%
INVAInnoviva Inc3.15-407.47%
VXRTVaxart Inc3.55-446.05%
CRMDCorMedix Inc3.63-453.72%
CVACCureVac N.V.4.45-533.39%
GLPGGalapagos NV4.86-573.67%
SRPTSarepta Therapeutics Inc4.88-575.93%
ABEOAbeona Therapeutics Inc5.39-625.20%
ABUSArbutus Biopharma Corp5.60-645.49%
ZVRAZevra Therapeutics Inc5.89-673.92%
SPROSpero Therapeutics Inc6.23-707.18%
CGENCompugen Ltd6.31-715.52%
RIGLRigel Pharmaceuticals6.87-769.93%
SLXNSilexion Therapeutics Corp7.30-811.26%
OMEROmeros Corporation9.26-1002.59%
AUPHAurinia Pharmaceuticals Inc9.58-1034.40%
PLXProtalix BioTherapeutics Inc10.89-1161.72%
ACADAcadia Pharmaceuticals Inc11.73-1243.36%
TBPHTheravance Biopharma Inc12.26-1295.38%
ADMAAdma Biologics Inc12.42-1310.59%
HRMYHarmony Biosciences Holdings Inc13.82-1447.27%
SABSSAB Biotherapeutics Inc14.14-1478.08%
NAGENiagen Bioscience Inc14.82-1544.56%
INCYIncyte Corp15.82-1642.47%
REGNRegeneron Pharmaceuticals Inc15.86-1645.80%
PBYIPuma Biotechnology Inc17.32-1788.04%
CPRXCatalyst Pharmaceuticals Inc17.44-1800.09%
EXELExelixis Inc17.54-1809.71%
TGTXTG Therapeutics Inc18.97-1948.92%
MDXGMimedx Group Inc20.55-2103.58%
XOMAXOMA Royalty Corp22.87-2330.02%
ARGXArgen X SE24.30-2468.77%
CTMXCytomX Therapeutics Inc24.82-2519.77%
XOMAOXOMA Royalty Corp25.34-2570.83%
HALOHalozyme Therapeutics Inc25.62-2598.01%
XOMAPXOMA Royalty Corp25.67-2602.54%
VRTXVertex Pharmaceuticals Inc27.99-2829.16%
RPRXRoyalty Pharma plc - Class A28.69-2896.70%
SLNOSoleno Therapeutics Inc29.02-2928.66%
ASNDAscendis Pharma A/S30.09-3032.99%
LGNDLigand Pharmaceuticals Inc - Class B37.91-3795.98%
APLSApellis Pharmaceuticals Inc39.02-3904.12%
BMRNBiomarin Pharmaceutical Inc42.21-4215.17%
KRYSKrystal Biotech Inc45.34-4520.46%
ONCBeiGene Ltd69.54-6879.39%
PHARPharming Group N.V.75.03-7414.13%
TECHBio-Techne Corp101.96-10039.77%
VCELVericel Corp109.92-10816.06%
ALNYAlnylam Pharmaceuticals Inc117.96-11600.24%
GMABGenmab140.29-13776.73%
TLXTelix Pharmaceuticals Ltd162.15-15908.03%
CORTCorcept Therapeutics Inc212.86-20851.15%